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Abstract
Background: Inflammatory bowel disease (IBD) is a debilitating chronic disease characterised by inflammation
and ulceration of the gastrointestinal tract. It is associated with a range of debilitating symptoms and reduced
quality of life. People living with IBD may also be at risk of body image dissatisfaction (BID). BID is a distorted and
negative view of the physical self, which in turn can adversely affect mental health and quality of life. To date,
there have been no systematic reviews of the evidence on BID in IBD patients. Therefore, the aim of this
systematic review is to clarify the evidence base on BID in *IBD patients including (i) the tools used to measure
BID, (ii) the prevalence and severity of BID, (iii) the risk factors associated with BID and (iv) the relationship
between BID and quality of life.
Methods: Bibliographic databases (EMBASE, MEDLINE, PsycINFO, Cochrane CENTRAL) will be searched using a
sensitive search strategy aiming to identify any quantitative study reporting on body image in the context of IBD.
This will be supplemented by searches of ongoing trials registers and checking of reference lists. Studies will be
assessed for eligibility using predetermined selection criteria for each question. Data will be extracted using a
predefined data extraction form, and risk of bias (quality) of included studies will be assessed based on checklists
appropriate to the study designs identified. Key methodological steps will be undertaken in duplicate to minimise
bias and error. Synthesis will be undertaken separately for the different systematic review sub-questions. Given
the anticipated heterogeneity of evidence on each question, it is likely that synthesis will be mostly narrative.
Discussion: To the best of our knowledge, this will be the first systematic review to collate the existing evidence
on BID in IBD patients. Understanding the impact of BID, its relationship with quality of life, and which patients
may be at greater risk, may ultimately lead to the development of interventions to prevent or treat BID and to
better patient care. Any gaps in the identified evidence will help to inform the research agenda in this area.
Systematic review registration: PROSPERO: (CRD42018060999).
Keywords: Systematic review, Inflammatory bowel disease, Ulcerative colitis, Crohn’s disease, Body image
Background
Inflammatory bowel disease (IBD) is a chronic gastrointes-
tinal disease characterised by inflammation and ulceration
of the gastrointestinal tract. IBD consists of two main
forms: Crohn’s disease and ulcerative colitis [1]. Ulcerative
colitis affects the large intestine, whereas Crohn’s disease
can affect the entire digestive tract [2]. Around 300,000
people in the UK are affected by Crohn’s or colitis [3], as
well as 2.5 million across Europe and over 1 million in the
USA [4]. IBD is often diagnosed at a young age and
equally in men and women. Symptoms are often debilitat-
ing and can affect day-to-day activities [5]. Patients may
suffer from severe abdominal pain, bloody diarrhoea,
weight loss, fatigue and other symptoms such as anaemia,
vomiting and fever [6, 7]. An individual may have periods
of time when their illness flares up, as well as times when
they are in remission [2].
Currently, the cause of IBD is unknown; however, gen-
etic and environmental factors are thought to play a part
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and IBD is considered as an autoimmune disease [8, 9]. Al-
though there is no cure, treatments include aminosalicy-
lates and steroids to reduce inflammation and
immunosuppressants to reduce the autoimmune response
in the gastrointestinal tract [10, 11]. Around 20% of pa-
tients do not respond to treatments and surgery is consid-
ered as an option to remove or repair the damaged part of
the digestive system [2]. Studies have also shown that pa-
tients with IBD may have a reduced health-related quality
of life compared to the general population, particularly
when their disease is active and more so in women than in
men [12, 13].
Body image is how an individual perceives themselves
physically and body image dissatisfaction (BID) is associ-
ated with a distorted and negative view of oneself causing
feelings of anxiousness and discomfort [14]. Generally,
women are more likely to suffer with BID than men [15].
Furthermore, having negative body image can have a ser-
ious impact on health and well-being [16]. Studies have
shown that patients with negative body image are more
likely to suffer with depression, anxiety and suicidal feel-
ings [17]. BID can also impact negatively upon relation-
ships [18] and quality of life [19].
Society has an impact on an individual’s perception of
body image with increased pressure on both men and
women to adhere to “ideal” bodies and consequentially
some people are more critical of themselves [20]. As-
pects such as body weight, body shape and skin prob-
lems such as acne, may contribute toward an individual’s
negative body image [21].
People who live with IBD may be at risk of BID for
various reasons. Condition-specific symptoms like swell-
ing of the stomach, anaemia and the less common ery-
thema nodosum (painful red skin nodules) may be an
issue [2, 22]. Factors such as disease activity, severity
and fatigue may also contribute to the dissatisfaction
with body image experienced by the patient. Therapies
also have an impact and steroid use is often associated
with weight gain, acne, mood swings and “moon face”
[23] (when fat is redistributed to the sides of the face
and excess water retention occurs [24]). Surgical resec-
tion of the bowel causing cosmetic scarring and the im-
plementation of a stoma may also add to BID [25, 26].
Most IBD patients are diagnosed at adolescence [2], a
time in life when body image becomes more important
and self-consciousness rises. Adolescents are at risk of
mental health issues like anxiety and depression [27] and
this risk is increased by long-term physical illnesses like
IBD [28]. This could be further intensified by BID, lead-
ing to possible extreme reactions such as self-harm or
feeling suicidal [29, 30].
Body image is not currently considered as an import-
ant aspect of care and treatment for IBD patients, al-
though some research suggests that it could potentially
be a problem [22]. As body image has been highlighted
as an issue in other conditions such as cancer and in
transplant patients [31], it is possible it may impact on
IBD patients too. Studies in these areas [32, 33] have
shown that body image may be associated with reduced
quality of life measures.
Current evidence and rationale
Scoping searches for existing evidence were carried out
in EMBASE, MEDLINE, the Cochrane Library and
PROSPERO (November 2017) using various terms to en-
compass IBD and body image (including inflammatory
bowel disease, ulcerative colitis, Crohn’s disease, IBD,
body image, body dissatisfaction). No existing or ongoing
systematic reviews on body image in IBD were identified.
However, the searches identified in excess of 20 primary
studies relating to different aspects of body image in IBD.
Studies variously explored measurement tools for BID,
prevalence, factors associated with BID in IBD and
quality-of-life. A systematic review is therefore warranted
to synthesise and clarify this heterogeneous evidence base.
The following four questions will be addressed in this
systematic review in order to develop an understanding
of the evidence around BID in IBD patients:
1. What tools are used to measure body image in IBD
patients and what are their components?
2. What is the prevalence and severity of body image
dissatisfaction in IBD patients?
3. What factors are associated with body image
dissatisfaction in IBD patients?
4. Is there an association between body image
dissatisfaction and quality of life in IBD patients?
Methods
This systematic review protocol has been prepared accord-
ing to the Preferred Reporting Items of Systematic Reviews
and Meta-Analysis Protocols (PRISMA-P) [34] statement
and is also registered on PROSPERO (CRD42018060999).
Search strategy
Bibliographic databases (EMBASE, MEDLINE, Psy-
cINFO, Cochrane CENTRAL) will be searched using a
sensitive search strategy aiming to identify any study
reporting on body image in the context of IBD. Index
and free text terms for IBD and body image will be com-
bined. Strategies will be adapted for each database and
run without date or language restrictions. No study de-
sign filters will be applied. Ongoing trials databases
(Clinicaltrials.gov and EU Clinical Trial Register) will be
searched for any current trials assessing body image.
Reference lists for each article included in the systematic
review will also be checked. Results will be managed using
Endnote X7 (Clarivate Analytics) to facilitate automatic
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and manual removal of duplicate records, study screening
and selection and record keeping. An example search
strategy for MEDLINE is shown in Table 1.
Screening and selection criteria
All identified records will be screened by two reviewers
(SB and IH) independently based on the criteria listed
below. Full texts will be acquired for any potentially rele-
vant studies. Where articles cannot be obtained, authors
will be contacted. Reasons for exclusion of studies will
be recorded. Should potentially relevant non-English
language studies be identified, part translation of rele-
vant portions of articles will be undertaken where feas-
ible. Selection criteria are as follows:
Question 1. What tools are used to measure body
image in IBD patients and what are their components?
Study design: any primary studies reporting quantita-
tive data will be eligible. The most likely study designs
will be cross-sectional and cohort studies, but it is pos-
sible that relevant data may be reported as part of a ran-
domised controlled trial. Qualitative research will be
excluded.
Publication type: conference abstracts identified in
searches of bibliographic databases will be included if
they were published up to 3 years before date of searches
and no subsequent full publication can be identified.
Population: patients of any age diagnosed with IBD. At
least 50% of population must have IBD unless results are
reported separately for sub-groups of individuals with IBD.
Tools: any tool measuring any aspect of body image
(including relevant domains or questions of quality of
life tools). Tools specific to certain subgroups, e.g.
stoma-based questionnaires will only be included if rele-
vant questions on body image are part of the tool.
The following eligibility criteria will additionally need to
be met for studies to be relevant for each of questions 2–4:
Question 2. What is the prevalence of body image
dissatisfaction in IBD patients?
Include: studies that report prevalence/frequency and
severity of BID (including mean/median body image
scores) in IBD patients.
Question 3. What factors are associated with body
image dissatisfaction in IBD patients?
Include: studies where data is reported on associations be-
tween any factor in inflammatory bowel disease patients and
BID. This might include factors such as age, gender, disease
activity, medication, age at onset and disease subtype.
Question 4. Is there an association between body image
dissatisfaction and quality of life in IBD patients?
Include: studies that have looked at the association be-
tween results from body image tools and quality of life
tools in patients with a diagnosis of inflammatory bowel
disease. This might include an association between two
separate domains of the same tool (e.g. body image and
physical quality of life).
Data extraction
Data extraction will be performed independently by two
reviewers, SB and IH, with discrepancies resolved
through discussion or referral to a third reviewer (DM).
A pre-designed piloted data extraction sheet will be
used. Authors will be contacted if any clarification of re-
ported information is required. Data to be extracted will
include study characteristics, patient characteristics and
data needed for analysis, with examples shown below.
Study characteristics
Study characteristics include study design, inclusion/ex-
clusion criteria for study, recruitment methods, aim of
study, follow-up period and study setting.
Table 1 Example search strategy for MEDLINE database
Search Query
#1 exp inflammatory bowel diseases/
#2 inflammatory bowel disease*.mp.
#3 exp Colitis, Ulcerative/
#4 ulcerative colitis.mp.






#11 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10










#22 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18 OR 19 OR 20 OR 21
#23 11 AND 22
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Participant characteristics
Participant characteristics include number of patients,
age, gender, type of inflammatory bowel disease, severity
of disease, disease activity, BMI, comorbidities and ther-
apy/surgery.
Data for synthesis/analysis
Data for synthesis include body image measurement
tool, components of body image tools/scales, data on
body image dissatisfaction (e.g. body image scores,
prevalence, thresholds for determining BID), factors as-
sociated with body image dissatisfaction and how this
has been quantified, quality of life measures and associ-
ation between body image and quality of life.
Quality assessment
Assessment of study quality will be performed alongside
data extraction. SB and IH will independently undertake
quality assessment, with discrepancies resolved through
discussion or referral to DM. Quality assessment will be
based on checklists from the Joanna Briggs Institute critical
appraisal tools [35]. The most relevant checklists will be
those for cross-sectional analytical studies, cross-sectional
prevalence studies and cohort studies. Other study designs
may report relevant data; for example, relevant cross-sec-
tional data may be presented in the context of a rando-
mised controlled trial. In this case, the quality items for
cross-sectional studies will still be relevant.
Important quality items will likely relate, for example,
to sample selection, response rate during enrolment in
the study and measurement of outcomes in a valid and
reliable way.
Synthesis/analysis
Evidence for each of the four questions will be synthesised
separately. Summary tables of study characteristics will be
produced for each question as well as an overall risk of
bias table. Given the anticipated heterogeneity (e.g. differ-
ences in study design, measurement tools, population and
outcome statistics), it is likely that synthesis will be narra-
tive, with key findings tabulated. The feasibility of
meta-analysis will be considered but will be dependent on
clinical and methodological homogeneity. If feasible, a
random effects model is more likely to be appropriate.
Relevant outcome metrics that would be considered
for pooling are BID prevalence proportions or mean
body image scores, odds ratios/risk ratios or correlation
coefficients relating to the association between different
factors. If meta-analysis is carried out, the I2 statistic will
be used to measure the percentage of variation across
studies that is due to heterogeneity beyond that expected
by chance. If meta-analysis is not feasible, it may still be
possible to present findings in forest plots (without pool-
ing) for illustrative purposes.
Important subgroups relate to disease type and sever-
ity, body image measurement tool, gender and age.
Where possible, findings will be presented according to
different diseases/disease severities and different tools.
Further consideration of subgroups will likely be limited
to those reported within primary studies. Quality assess-
ment findings will be used in considering the strength of
evidence for each of the four questions. Formal sensitiv-
ity analysis based on quality assessment findings is un-
likely to be feasible. Funnel plots will be used to assess
publication bias alongside Egger’s test [36] for each out-
come were meta-analysis is possible and where there are
ten or more studies contributing data.
Discussion
To the best of our knowledge, this will be the first sys-
tematic review exploring BID in IBD patients. It will re-
veal all evidence on BID in IBD including how it is
measured, the prevalence and severity of BID, possible
risk factors in IBD patients and any associations between
BID and quality of life. Any gaps in the evidence base
will also be highlighted, which will be useful for inform-
ing future research recommendations.
Whilst NICE quality standards for IBD recognise enhan-
cing quality of life in their outcome framework [37], nei-
ther this nor any other guidelines currently consider body
image factors in the treatment and care decision-making in
IBD. At present, it is unclear to what extent BID issues im-
pact on quality of life and which, if any, quality of life mea-
sures are capturing aspects relating to BID. Elucidating the
relationship between body image dissatisfaction and quality
of life in this patient group is therefore important.
It is known that individuals with BID are at risk of de-
pression, anxiety and potentially even self-harm [38]. It
is also known that individuals are more likely to suffer
with mental health issues if they have a long-term phys-
ical health condition [39]. If BID is prevalent in IBD pa-
tients, they could be at increased risk of these
conditions. Therefore, it is important that IBD clinicians
and patients are made aware of any risks, which would
allow for early intervention to prevent or ameliorate
BID. If certain risk factors are found to be associated
with BID in IBD patients, these could be used to identify
which individuals are particularly at risk.
Ultimately, this might lead to interventions being de-
veloped and implemented that aim to improve body
image, thereby reducing further mental health risks and
improving quality of life.
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